Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Exxon Mobil Corporation (XOM) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exxon Mobil Corporation (XOM) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for August 3rd
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 3rd:
SouthState Corporation (SSB - Free Report) : This bank holding company for SouthState Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.
SouthState Corp. Price and Consensus
SouthState Corp. price-consensus-chart | SouthState Corp. Quote
SouthState’s shares gained 4.3% over the last three months compared with the S&P 500’s decline of 1.4%. The company possesses a Momentum Score of A.
SouthState Corp. Price
SouthState Corp. price | SouthState Corp. Quote
Exxon Mobil Corporation (XOM - Free Report) : This explorer and producer of crude oil and natural gas has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 19% over the last 60 days.
Exxon Mobil Corporation Price and Consensus
Exxon Mobil Corporation price-consensus-chart | Exxon Mobil Corporation Quote
Exxon Mobil’s shares gained 6.6% over the last three months compared with the S&P 500’s decline of 1.4%. The company possesses a Momentum Score of B.
Exxon Mobil Corporation Price
Exxon Mobil Corporation price | Exxon Mobil Corporation Quote
argenx SE (ARGX - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.3% over the last 60 days.
argenex SE Price and Consensus
argenex SE price-consensus-chart | argenex SE Quote
argenx’s shares gained 20.5% over the last three months compared with the S&P 500’s decline of 1.4%. The company possesses a Momentum Score of A.
argenex SE Price
argenex SE price | argenex SE Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.